Long-term treatment of acromegalic patients with repeatable parenteral depot-bromocriptine

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Clinical Investigation

• Publication date

  1993-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00208479PMID 8374248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Size heterogeneity of circulating growth hormone in acromegaly. "Big-big" GH forms are associated with inappropriately low IGF-I levels.

  1991cited by this paper
• Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR®) for the treatment of acromegaly

  1991cited by this paper
• A randomized study of SMS 201-995 versus bromocriptine treatment in acromegaly: clinical and biochemical effects.

  1990cited by this paper
• Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion.

  1988cited by this paper
• INVESTIGATION OF THE CRITERIA FOR ASSESSING THE OUTCOME OF TREATMENT IN ACROMEGALY

  1987cited by this paper
• DEPOT‐BROMOCRIPTINE TREATMENT FOR PROLACTINOMAS AND ACROMEGALY

  1986cited by this paper
• PARENTERAL BROMOCRIPTINE IN THE TREATMENT OF HORMONALLY ACTIVE PITUITARY TUMOURS

  1986cited by this paper
• Changes of molecular forms of growth hormone in bromocriptine treated acromegaly in relation to changes of somatomedin-C and clinical response.

  1985cited by this paper
• Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.

  1985cited by this paper
• HOW EFFECTIVE IS EXTERNAL PITUITARY IRRADIATION FOR GROWTH HORMONE‐SECRETING PITUITARY TUMOURS?

  1984cited by this paper
• Drugs Five Years Later: Bromocriptine

  1984cited by this paper
• Successful pregnancy in an acromegalic patient during 2-Br-alpha-ergocryptine (CB-154) therapy.

  1982cited by this paper
• CHANGES IN CIRCULATING SOMATOMEDIN‐C LEVELS IN BROMOCRIPTINE‐TREATED ACROMEGALY

  1982cited by this paper
• ERRATA: TREATMENT OF ACROMEGALY BY TRANS‐SPHENOIDAL OPERATION, 90‐YTTRIUM IMPLANTATION AND BROMOCRIPTINE: RESULTS IN 230 PATIENTS

  1982cited by this paper
• TREATMENT OF ACROMEGALY BY TRANS‐SPHENOIDAL OPERATION, 90‐YTTRIUM IMPLANTATION AND BROMOCRIPTINE: RESULTS IN 230 PATIENTS

  1982cited by this paper
• Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C.

  1981cited by this paper
• Long-term treatment of acromegaly with bromocriptine.

  1977influential reference
• Long-term Treatment of Acromegaly with Bromocryptine: Postprandial HGH Levels and Response to TRH and Glucose Administration

  1976cited by this paper
• Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration.

  1974cited by this paper
• DECREASED PLASMA GROWTH HORMONE (GH) LEVELS IN ACROMEGALICS FOLLOWING CB 154(2-Br-α-ERGOCRYPTINE) ADMINISTRATION1

  1974cited by this paper

• Outcome of pregnancies in a large cohort of women with acromegaly

  2018cites this paper
• General health status and intelligence scores of children of mothers with acromegaly do not differ from those of healthy mothers

  2016cites this paper
• Pituitary disease in pregnancy

  2012cites this paper
• Best Practice & Research Clinical Endocrinology & Metabolism

  2011cites this paper
• Pregnancy and other pituitary disorders (including GH deficiency).

  2011cites this paper
• Pregnancy and pituitary disorders.

  2010cites this paper
• Treatment results of acromegaly as analyzed by different criteria

  2005cites this paper
• Medical Management of Pituitary Adenomas: The Special Case of Management of the Pregnant Woman

  2004cites this paper
• Current management of acromegaly

  2000cites this paper
• [Current concepts in the diagnosis and treatment of acromegaly].

  1996cites this paper